Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG
{{output}}
Introduction: The AbC-19™ lateral flow immunoassay (LFIA) performance was evaluated on plasma samples from a SARS-CoV-2 vaccination cohort, WHO international standards for anti-SARS-CoV-2 IgG (human), individuals ≥2 weeks from ... ...
